journal articleLitStream CollectionAccess to tobramycin dry-powder inhaler to improve in Canada2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-201106390-00020pmid: N/A
journal articleLitStream CollectionCatumaxomab approved for reimbursement in Belgium2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-201106390-00022pmid: N/A
journal articleLitStream CollectionAustralian PBS announces new listings and price changes2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-201106390-00021pmid: N/A
journal articleLitStream CollectionLarge growth predicted for generic drug market2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-201106390-00027pmid: N/A
journal articleLitStream CollectionGenerics save US consumers and healthcare system $ billions2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-201106390-00025pmid: N/A
journal articleLitStream CollectionMore countries to benefit from GAVI vax funding for child killers2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-201106390-00028pmid: N/A
journal articleLitStream CollectionChina set to become third-largest pharma market by 20132013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-201106390-00024pmid: N/A
journal articleLitStream CollectionHealth Economics and Outcomes Research funding to rise in 20122013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-201106390-00026pmid: N/A
journal articleLitStream CollectionNovel disease-modifying therapies drive up the MS drug market2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-201106390-00029pmid: N/A
journal articleLitStream CollectionPreferred brand tier for tofacitinib2013 PharmacoEconomics & Outcomes Newsdoi: 10.2165/00151234-201106390-00033pmid: N/A